Clinical Trial Update: Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study [Phase 3]

View source ↗

Summary

A Phase 3 trial (DIMWAP) evaluating Dysport (abobotulinumtoxinA) for migraine prevention without aura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Migraine Without Aura Prophylaxis | Phase 3 | Status: COMPLETED